Scientific Papers 10 December 2021 An Evolutionary Portrait of the Progenitor SARS-CoV-2 and Its Dominant Offshoots in COVID-19 Pandemic
pre-print 28 November 2021 Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response
Scientific Papers 24 May 2021 NEWS2 Score is more accurate than COVID-GRAM for prediction of Critical illness
Clinical Trials 7 May 2020 Hydroxychloroquine, Azithromycin, Ivermectin and Camostat Mesilate - Clinical Trial
Scientific Papers 3 May 2020 Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance Mini-Review published [https://www.sciencedirect.com/science/article/pii/S2052297520300366#bib14] in New Microbes and New Infections [https://www.sciencedirect.com/science/journal/20522975] journal
Scientific Papers 2 May 2020 Temperature and humidity decreases daily new cases and new deaths of COVID-19 Pre-print published [https://www.ncbi.nlm.nih.gov/pubmed/32361460]in the science of the total environment journal [https://www.journals.elsevier.com/science-of-the-total-environment](Elsevier
Therapeutics 1 May 2020 Convalescent serum lines up as first-choice treatment for coronavirus Published in Nature Biotechnology: [https://www.nature.com/articles/d41587-020-00011-1] Antibodies from blood donated by people who recovered from the illness and hyper-immunoglobulins are becoming
Clinical Trials 30 April 2020 NIH Clinical Trial endorses Remdesivir The Interim analysis released by (an independent) data and safety board (DSMB) overseeing the Adaptive COVID-19 Treatment Trial (ACTT) [https://www.niaid.nih.gov/news-events/
